Companies › Elevance Health · Global Markets & Policy
Elevance Health
- NYSE: ELV
U.S.-listed company (NYSE: ELV) that the SEC classifies under industry code 6324, "Hospital & Medical Service Plans".
Next earnings report: Oct 21, 2026. Elevance Health quarterly results and earnings history →
Insider trades (Form 4)
Last 120 days: open-market sales $0, purchases $1.4M. All Elevance Health insider transactions →
| Date | Insider | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jul 17, 2026 | Ramiro G Peru Director | Open-market purchase | 1,000 | $366.05 | $366K | Form 4 ↗ |
| Jul 17, 2026 | Gail Boudreaux President and CEO, Director | Open-market purchase | 680 | $366.41 | $249K | Form 4 ↗ |
| Jul 17, 2026 | Gail Boudreaux President and CEO, Director | Open-market purchase | 2,045 | $368.25 | $753K | Form 4 ↗ |
Key financials
| Metric | FY to Dec 2022 | FY to Dec 2023 | FY to Dec 2024 | FY to Dec 2025 |
|---|---|---|---|---|
| Revenue | $156.6B | $171.3B | $177.0B | $199.1B |
| Operating income | $8.3B | $8.5B | $7.9B | $7.2B |
| Net income | $5.9B | $6.0B | $6.0B | $5.7B |
| Diluted EPS | $24.28 | $25.22 | $25.68 | $25.21 |
Fiscal years, from annual reports (10-K / 20-F). Source: SEC EDGAR (XBRL company facts), retrieved 2026-10-14. Verify figures against the original filings.
Recent filings
- 2026-09-10 · 8-K — Regulation FD disclosure
- 2026-07-15 · 10-Q
- 2026-07-15 · 8-K — Results of operations
- 2026-06-10 · 8-K — Regulation FD disclosure
- 2026-05-13 · 8-K — Shareholder vote results
- 2026-04-22 · 10-Q
- 2026-04-22 · 8-K — Results of operations
- 2026-03-27 · DEF 14A
Source: SEC EDGAR, retrieved 2026-10-14. Filing types explained: 8-K, 10-Q, 10-K, 20-F / 6-K.
Not investment advice. This page lists official filings and our reports for reference. SignalStack does not rate securities or recommend buying or selling anything.